PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

Phase 1 Completed 30 enrolled Dong-A ST Co., Ltd.

Non-randomizedParallel-groupOpen-label

Summary

This is a clinical study to investigate the pharmacokinetics/pharmacodynamics and tolerability of DA-1229(Evogliptin) tabletin renal impaired patients.

Timeline

Start: 2014-07
Primary completion: 2015-03
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Evogliptin	Small molecule	—	—

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

Summary

Timeline

Drugs

Indications